SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-16-024108
Filing Date
2016-01-27
Accepted
2016-01-27 06:12:13
Documents
3
Period of Report
2016-01-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K resx20160126_8k.htm 8-K 24585
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 13914
3 ex99-1img001.jpg GRAPHIC 4077
  Complete submission text file 0001437749-16-024108.txt   45647
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24477 | Film No.: 161362942
SIC: 2834 Pharmaceutical Preparations